1. Home
  2. Our Firm
  3. News
  4. Guggenheim Securities Receives Regulatory Approval for Its Acquisition of Former Lazard Capital Markets London Operations

Our Firm

January 15, 2015

Guggenheim Securities Receives Regulatory Approval for Its Acquisition of Former Lazard Capital Markets London Operations

NEW YORK – Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, today announced that it has received regulatory approval from the Financial Conduct Authority in the UK for Guggenheim’s acquisition of the London operations of FM Partners Holdings, formerly known as Lazard Capital Markets International Limited.

Closing of the acquisition is expected on January 31, 2015. The acquisition allows Guggenheim to conduct a range of sales and trading operations, initially focusing on European corporate, financial and structured credit, as well as expanding distribution of U.S. equities. Guggenheim plans to operate the business under the new name of Guggenheim Securities International Ltd.

The office is located at The Peak, 5 Wilton Road, London, England, SW1V 1AN and reachable at +44 20 3059 6600.


About Guggenheim Partners

Guggenheim Partners is a global investment and advisory firm with more than $220 billion in assets under management. Across our three primary businesses of investment management, investment banking, and insurance services, we have a track record of delivering results through innovative solutions. With more than 2,500 professionals based in more than 25 offices around the world, our commitment is to advance the strategic interests of our clients and to deliver long-term results with excellence and integrity.



April 15, 2019

Guggenheim Securities Hires Jason Truman to Expand Healthcare Investment Banking Group

Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, announced today that Jason Truman will join the firm as a Senior Managing Director in the firm’s Healthcare investment banking group.

Read More

March 20, 2019

Dana Flanders Joins Guggenheim Securities as Therapeutics Analyst

Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, announced today that Dana Flanders will join the firm in May as a Director in a planned expansion of the Healthcare research team.

Read More



© 2019 Guggenheim Partners, LLC. All rights reserved. Guggenheim, Guggenheim Partners and Innovative Solutions. Enduring Values. are registered trademarks of Guggenheim Capital, LLC.